Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Oct 8, 2020	R3 Vascular	$17.8M Other Equity / Series A	415 Capital	HBM-MedFocus
Feb 25, 2020	Viseon	$18.0M Series B	HBM-MedFocus, Invus Opportunities, Wexford Capital	—
Oct 17, 2019	AZTherapies	$26.3M Series C	Cosine, Tas Parafestas	Drads Capital, IBS Capital
Sep 6, 2018	Specialty Renal Products(SRP)	$3.0M Series A	Arbor Capital, Wexford Capital	—
Sep 26, 2017	Viseon	$5.0M Series A	HBM-MedFocus, Invus Opportunities, Wexford Capital	—
Jul 25, 2017	Shape Memory Medical	$14.0M Series B	HBM Healthcare Investments	Emergent Medical Partners, HBM-MedFocus
Nov 16, 2015	ElMindA	$28.0M Series C	—	HealthCrest, OurCrowd, Palisade Capital Management, Tianqiao Chen 陈天桥, Robert Kraft, Bill Hambrecht
Jan 20, 2015	Dig Inn	$15.0M Series C	Wexford Capital	—
Aug 29, 2012	Sophono	$7.0M Series B	Mark D.Zand	—
Jun 1, 2012	Invuity	$25.0M Series D	Eric Roberts	aMoon Fund, Domain Associates, InterWest, Osage University Partners, Vivo Capital, InterWest Partners, Kleiner Perkins
Aug 2, 2011	Ellipse Technologies	$17.6M Series C	BioStar Ventures, HBM Healthcare Investments	MedFocus Funds
Sep 28, 2010	Tigris Pharmaceuticals	$6.5M Series C	Neil Flanzraich	Sonostar Capital Partners
Mar 30, 2010	Reverse Medical	$14.0M Series B	—	BioStar Ventures, Early Stage Partners, Emergent Medical Partners, Getz Brothers, MedFocus Funds, NBGI Ventures, South Australian Life Science Advancement Partnership

Financial History

Leadership Team